<code id='AA579678EF'></code><style id='AA579678EF'></style>
    • <acronym id='AA579678EF'></acronym>
      <center id='AA579678EF'><center id='AA579678EF'><tfoot id='AA579678EF'></tfoot></center><abbr id='AA579678EF'><dir id='AA579678EF'><tfoot id='AA579678EF'></tfoot><noframes id='AA579678EF'>

    • <optgroup id='AA579678EF'><strike id='AA579678EF'><sup id='AA579678EF'></sup></strike><code id='AA579678EF'></code></optgroup>
        1. <b id='AA579678EF'><label id='AA579678EF'><select id='AA579678EF'><dt id='AA579678EF'><span id='AA579678EF'></span></dt></select></label></b><u id='AA579678EF'></u>
          <i id='AA579678EF'><strike id='AA579678EF'><tt id='AA579678EF'><pre id='AA579678EF'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:9
          Exterior photo of UnitedHealth Group building
          Courtesy UnitedHealth Group

          UnitedHealth Group has about 90,000 employed or affiliated doctors, approximately 10% of all physicians in the U.S.

          The number — disclosed Wednesday at the company’s investor day by Amar Desai, the CEO of UnitedHealth’s Optum Health division — means the company acquired or hired 20,000 doctors in the past year alone.

          advertisement

          The rapid growth of UnitedHealth’s physician base underscores how the company, which already is the country’s largest private health insurer, is looking to control more of the health care delivery system, and how this growth is going unchecked by antitrust agencies.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Inari Medical to buy amputation prevention company LimFlow
          Inari Medical to buy amputation prevention company LimFlow

          Inariwillpay$250millionupfrontand$165moredependingonLimFlow’scommercialsuccess.DavidGregory&Debb

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Explaining an after

          AdobeThisarticlewasadaptedfromSTAT’slatestreport,“Subgroupanalysis:howtoevaluateposthoctestsforsigni